Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Acalabrutinib
The First People's Hospital of Lianyungang
Chronic Lymphocytic Leukemia
1 trial -
Accelerated partial breast irradiation
Universal Integrated
Breast Cancer
1 trial -
Acetaminophen
Hospital Authority, Hong Kong
Elbow Fracture
1 trial -
Akkermansia Probiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colo-rectal Cancer
1 trial -
Albumin Human
United Therapeutics Europe Ltd
Burn Injury
1 trial -
Albumin paclitaxel/neutrophil drug
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
Albumin-Bound Paclitaxel
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Carcinoma
1 trial -
Albuterol
The First People's Hospital of Lianyungang
Chronic Obstructive Pulmonary Disease
1 trial -
Albuterol eMDPI DS
Teva Pharma GmbH
Pulmonary Disease, Chronic Obstructive
1 trial -
Alcohol(oral) and placebo
BRIGHT MINDS BIOSCIENCES INC.
Alcohol Drinking
1 trial -
Amberen
The First People's Hospital of Lianyungang
Climacteric Syndrome
1 trial -
Ambrisentan
The First People's Hospital of Lianyungang
Pulmonary Arterial Hypertension
1 trial -
Amino acid based formula
United Therapeutics Europe Ltd
Cow Milk Allergy
1 trial -
Amorphous calcium carbonate
Universal Integrated
Calcium
1 trial -
Amoxicillin
Universal Integrated
Human Gut Microbiota
1 trial -
Amway Herbal Drink
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Skin Laxity
1 trial -
Anlotinib Hydrochloride
The First People's Hospital of Lianyungang
Non-Small-Cell Lung
1 trial -
Anlotinib hydrochloride
The First People's Hospital of Lianyungang
Non-Small-Cell Lung Cancer
2 trials -
Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis.
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Autoimmune Diseases
1 trial -
Anti-infective therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchiectasis Adult
1 trial -
Antibiotic selection based on the antibiotic susceptibility testing
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastritis
1 trial -
Antioxidant
AYTU BIOPHARMA, INC
Compare the sORP Rate in Sperm Samples, Obtained by the Mioxsys System, Before and After 2.5 Months Antioxidant Men Supplements Treatment (Fertybiotic Man)
1 trial -
Antioxidant Berry Supplementation
United Therapeutics Europe Ltd
Heat Intolerance
1 trial -
Anvitra Gastric Suspension
Hong Kong Baptist University
GERD (Heartburn, Regurgitation, and Dyspepsia) Frequency
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources